<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CEB496D0-8DC8-4905-8F65-D1ACDAD75C9B"><gtr:id>CEB496D0-8DC8-4905-8F65-D1ACDAD75C9B</gtr:id><gtr:name>Oxford Brookes University</gtr:name><gtr:address><gtr:line1>Headington Campus</gtr:line1><gtr:line2>Gipsy Lane</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX3 0BP</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Structural Biology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CEB496D0-8DC8-4905-8F65-D1ACDAD75C9B"><gtr:id>CEB496D0-8DC8-4905-8F65-D1ACDAD75C9B</gtr:id><gtr:name>Oxford Brookes University</gtr:name><gtr:address><gtr:line1>Headington Campus</gtr:line1><gtr:line2>Gipsy Lane</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX3 0BP</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D9E45FE5-3B25-4E8F-84CD-063C1CE3F9D0"><gtr:id>D9E45FE5-3B25-4E8F-84CD-063C1CE3F9D0</gtr:id><gtr:firstName>Ray</gtr:firstName><gtr:surname>Owens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2584032F-79DE-4183-A760-727AE45C4F32"><gtr:id>2584032F-79DE-4183-A760-727AE45C4F32</gtr:id><gtr:firstName>Yvonne</gtr:firstName><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2249CEB5-031F-47F4-B330-704BE07401EB"><gtr:id>2249CEB5-031F-47F4-B330-704BE07401EB</gtr:id><gtr:firstName>Karl</gtr:firstName><gtr:surname>Harlos</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/12A0F313-886D-4BE0-8854-7EE4A715ADD1"><gtr:id>12A0F313-886D-4BE0-8854-7EE4A715ADD1</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Stuart</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D6E69D6E-2D35-4DB1-B1EA-1C7F0B0FBD61"><gtr:id>D6E69D6E-2D35-4DB1-B1EA-1C7F0B0FBD61</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Grimes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B4B1810E-E1F6-4A58-B99A-22295ED1A3F9"><gtr:id>B4B1810E-E1F6-4A58-B99A-22295ED1A3F9</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Esnouf</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400717"><gtr:id>4E018DCB-FEF2-463B-909C-466B3E0E8FEC</gtr:id><gtr:title>A Protein Production Facility for Biomedically Driven Structural Proteomics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400717</gtr:grantReference><gtr:abstractText>The human genome project, over some 10-15 years, has advanced by many orders of magnitude DNA sequencing and the manipulation and management of large biological data bases. The resulting sequence of the human genome has been hailed as an epoch making achievement ushering in as yet largely uncharted opportunities for advances in human healthcare. At a pragmatic level it is generally accepted that such advances can only occur when the genomic information is complemented by advances in our understanding of protein function. A full functional description of a protein requires knowledge of its 3D structure, often as part of a large multi-molecular assembly, but the rate of determination of genomic sequences has far outstripped that of structure determination. The aim of the Oxford Protein Production Facility is to facilitate this process by developing high throughput tools for the over-expression and structure solution of human proteins and proteins from human pathogens. In the pilot phase the project has assembled a pipeline for protein production involving sophisticated data management and robotic technologies in several areas. These technologies are highly effective for proteins from bacterial pathogens and the challenge now is to refine these technologies to increase their effectiveness for human and viral proteins. Target selection will involve choosing areas where problems of biomedical importance can be advanced more effectively than by the application of standard laboratory methods. The intention is to mesh with well established networks of interdisciplinary research covering molecular, cellular and clinical studies. We have identified target areas addressing Niesseria proteins, viral proteins, human immune proteins and proteins relevant to cancer.</gtr:abstractText><gtr:technicalSummary>Future funding of the OPPF will be used to achieve three major goals. Firstly, to maintain UK structural biology at the fore front of technology development in high throughput protein production and crystallisation. Secondly to apply this technology to challenging biomedical problems through the development of a portfolio of collaborative projects. Thirdly to make current and future technology available to the wider biology community through training opportunities. These aims are obviously not mutually exclusive and to a large extent will be addressed together. 

COST MODEL: The costs in the electronic form represent the full costs of the OPPF project. However the consumable costs required from the MRC will be less since we will implement a cost recovery model, details of which are given in the research proposal.
Implementing this model produces a total projected cost to the MRC of #2,476,816 for the first 2 years and #5,041,564 for the total 4 years.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2500000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Brookes University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Life Sciences Oxford Brookes</gtr:department><gtr:description>Insect Cell Expression</gtr:description><gtr:id>32244C10-30A8-45CC-A853-7D3E613FF969</gtr:id><gtr:impact>Three publications in peer-reviewed journals: 19655260, 18781697, 20441568</gtr:impact><gtr:outcomeId>5131731E0B1-1</gtr:outcomeId><gtr:partnerContribution>Help in developing methods for insect cell expression</gtr:partnerContribution><gtr:piContribution>Testing and developing methods with Professor Linda King (Oxford Brookes University and Oxford Expression Technology Ltd)..</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Fab Cloning and Expression</gtr:description><gtr:id>F395FE83-4C26-4CB6-9C51-9B7482E62ADB</gtr:id><gtr:impact>Methods reported in 18662785 and Methods in Molecular Biology (in press)</gtr:impact><gtr:outcomeId>B82FFAA09F6-1</gtr:outcomeId><gtr:partnerContribution>Joint development</gtr:partnerContribution><gtr:piContribution>We have introduced a generic method for the production of antibody fragments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC collaborative grant</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5BA5DF02-B2AE-4788-BDBE-41D8B8BD8C44</gtr:id><gtr:outcomeId>rxHXVXnDVWY0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant/Meningitis UK</gtr:description><gtr:fundingOrg>Meningitis Now</gtr:fundingOrg><gtr:id>238A0F77-4ABB-4F4F-90F4-51B5FA923F82</gtr:id><gtr:outcomeId>NUK2HfGbdhZ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Vectors produced and distributed via MTAs</gtr:description><gtr:grantRef>G0400717</gtr:grantRef><gtr:id>C14D790D-0420-42D9-83EB-BEAB41A1D262</gtr:id><gtr:impact>Various structures</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>E86629B181D</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>pOPIN vectors</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Various expression vectors produced and antibody production method established (seePathology Collaboration for latter)</gtr:description><gtr:id>BD012800-311E-4340-B5A5-CB2BC7E281A3</gtr:id><gtr:impact>18988019 18662785 17317681 Above are pubmed ids for methods papers. Vectors have led to many results papers, which I dont have details of.</gtr:impact><gtr:outcomeId>304B435F018</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cloning</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18988024</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B5E7F4FA-D1CE-4D27-A071-A045925CAE34</gtr:id><gtr:title>High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1c55a629e4978a40d7271001f911ef7"><gtr:id>b1c55a629e4978a40d7271001f911ef7</gtr:id><gtr:otherNames>Beteva A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>155D96C29BC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C94E10BB-F373-418F-8803-E772AE09F905</gtr:id><gtr:title>A versatile ligation-independent cloning method suitable for high-throughput expression screening applications.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b27bdde20b47f12da8c33bb9c5e33377"><gtr:id>b27bdde20b47f12da8c33bb9c5e33377</gtr:id><gtr:otherNames>Berrow NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>977A8FB57B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C6161B-3A11-4406-80C9-6302ACFB3D0E</gtr:id><gtr:title>Glycoprotein structural genomics: solving the glycosylation problem.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68a136b0edbb71d5410f0ee7a4e92009"><gtr:id>68a136b0edbb71d5410f0ee7a4e92009</gtr:id><gtr:otherNames>Chang VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>60B6D2B9978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F515F019-C55F-428B-BA2B-21FBC386ECF7</gtr:id><gtr:title>The structure and transcriptional analysis of a global regulator from Neisseria meningitidis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba5128fcb9e215cb4a5503c3d8ebf348"><gtr:id>ba5128fcb9e215cb4a5503c3d8ebf348</gtr:id><gtr:otherNames>Ren J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>90A9DABC290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4002C3C-8607-4D74-AFE7-3E1D711A4C0E</gtr:id><gtr:title>Semi-automated microseeding of nanolitre crystallization experiments.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a351128a5243f5c920fb1009f9f34921"><gtr:id>a351128a5243f5c920fb1009f9f34921</gtr:id><gtr:otherNames>Walter TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>FABC5D49685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>972E0010-A46F-457B-90DA-C2E25B0C80B5</gtr:id><gtr:title>Structure of the Murray Valley encephalitis virus RNA helicase at 1.9 Angstrom resolution.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3374c52fb9c570d936935acdbf5dea71"><gtr:id>3374c52fb9c570d936935acdbf5dea71</gtr:id><gtr:otherNames>Mancini EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>F798F7C9BD0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EBC41A8-0603-48FE-BE85-F59BEF6708F9</gtr:id><gtr:title>Structure of the PII signal transduction protein of Neisseria meningitidis at 1.85 A resolution.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e25fd97c2e7ac4b9ce1c3a2a030ac7d2"><gtr:id>e25fd97c2e7ac4b9ce1c3a2a030ac7d2</gtr:id><gtr:otherNames>Nichols CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>9FF37274806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1221CA81-1082-45E6-B83D-7435F5A09AB0</gtr:id><gtr:title>SPINE bioinformatics and data-management aspects of high-throughput structural biology.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7e3e0a180914e2859cf7ddbf454e50d"><gtr:id>b7e3e0a180914e2859cf7ddbf454e50d</gtr:id><gtr:otherNames>Albeck S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>002319DAAFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE699029-20A4-4E00-9642-C5B13A0F9BB4</gtr:id><gtr:title>Structure of the cold-shock domain protein from Neisseria meningitidis reveals a strand-exchanged dimer.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba5128fcb9e215cb4a5503c3d8ebf348"><gtr:id>ba5128fcb9e215cb4a5503c3d8ebf348</gtr:id><gtr:otherNames>Ren J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>517EF3B73B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7DE0761-29E2-4EBD-BEC6-E4030040073F</gtr:id><gtr:title>Crystal structure of the Murray Valley encephalitis virus NS5 methyltransferase domain in complex with cap analogues.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8acfedd4763a384175bc1eb335a940dd"><gtr:id>8acfedd4763a384175bc1eb335a940dd</gtr:id><gtr:otherNames>Assenberg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>9426A73B884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2F80E21-0861-4870-A747-B00C96A4770B</gtr:id><gtr:title>Crystallization and preliminary X-ray analysis of CrgA, a LysR-type transcriptional regulator from pathogenic Neisseria meningitidis MC58.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd384d80006a1e0bb544b3221037a668"><gtr:id>bd384d80006a1e0bb544b3221037a668</gtr:id><gtr:otherNames>Sainsbury S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>0990BD6FCE6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63015E6A-CBC1-4C7C-B09A-5CB8EEF1AE8C</gtr:id><gtr:title>Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37f32e822e8e0b7391951838b0c2d46f"><gtr:id>37f32e822e8e0b7391951838b0c2d46f</gtr:id><gtr:otherNames>Au K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>46E12B922E3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F94DC6F7-3485-4B00-86CF-9C6E99D0E202</gtr:id><gtr:title>Structures of an alanine racemase from Bacillus anthracis (BA0252) in the presence and absence of (R)-1-aminoethylphosphonic acid (L-Ala-P).</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37f32e822e8e0b7391951838b0c2d46f"><gtr:id>37f32e822e8e0b7391951838b0c2d46f</gtr:id><gtr:otherNames>Au K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>D735103DC6B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>119D81CE-4208-4879-AC56-5951A0ACC634</gtr:id><gtr:title>The impact of protein characterization in structural proteomics.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b406f6ca91c28eb53d68429b5c8e5a1e"><gtr:id>b406f6ca91c28eb53d68429b5c8e5a1e</gtr:id><gtr:otherNames>Geerlof A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>9488650F3BE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F730C90C-053C-4150-8366-870FB088D7F5</gtr:id><gtr:title>Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/983a323eab978e639cf6b822f8107338"><gtr:id>983a323eab978e639cf6b822f8107338</gtr:id><gtr:otherNames>Alzari PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>BBC84F0BFC9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FC69A56-F45E-4177-B02B-F6A1DB9CF67B</gtr:id><gtr:title>Recombinant protein expression and solubility screening in Escherichia coli: a comparative study.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b27bdde20b47f12da8c33bb9c5e33377"><gtr:id>b27bdde20b47f12da8c33bb9c5e33377</gtr:id><gtr:otherNames>Berrow NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>5422540843A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95CF2106-C050-48D5-9E1F-A3C1916ADA0E</gtr:id><gtr:title>A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5083c27c32694a5a97d0d79ec526d5b9"><gtr:id>5083c27c32694a5a97d0d79ec526d5b9</gtr:id><gtr:otherNames>Nettleship JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn><gtr:outcomeId>43E0CB22F36</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5509427E-69D7-4245-8CAA-A383759A5AE6</gtr:id><gtr:title>Analysis of variable N-glycosylation site occupancy in glycoproteins by liquid chromatography electrospray ionization mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5083c27c32694a5a97d0d79ec526d5b9"><gtr:id>5083c27c32694a5a97d0d79ec526d5b9</gtr:id><gtr:otherNames>Nettleship JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn><gtr:outcomeId>76CD11E1861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B17AE93D-40A9-4D83-AA30-F7DE0C25339C</gtr:id><gtr:title>Expression, purification and crystallization of a lyssavirus matrix (M) protein.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8acfedd4763a384175bc1eb335a940dd"><gtr:id>8acfedd4763a384175bc1eb335a940dd</gtr:id><gtr:otherNames>Assenberg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>1153FD3C8F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B74865F-B69A-4ED7-A993-2255B69001B9</gtr:id><gtr:title>Application of the use of high-throughput technologies to the determination of protein structures of bacterial and viral pathogens.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2c0ec9d023d714de46fd3e268e5f99b"><gtr:id>b2c0ec9d023d714de46fd3e268e5f99b</gtr:id><gtr:otherNames>Fogg MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>FDC34F4EE67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD714F9C-DE11-4327-8660-AC8B843EEDB8</gtr:id><gtr:title>SPINE high-throughput crystallization, crystal imaging and recognition techniques: current state, performance analysis, new technologies and future aspects.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a0775b6412c242324a4a3911900dc5e"><gtr:id>2a0775b6412c242324a4a3911900dc5e</gtr:id><gtr:otherNames>Berry IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>82B3331CCD5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03AEF304-EEC5-4DF2-BCBF-A2AECD65F0FA</gtr:id><gtr:title>Generation of baculovirus vectors for the high-throughput production of proteins in insect cells.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6c6d931a40260165e1b86c02dbd2fa2"><gtr:id>b6c6d931a40260165e1b86c02dbd2fa2</gtr:id><gtr:otherNames>Possee RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>A8C442AB548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56EE8EE8-D5C1-4B0C-B37C-BA48222A8A05</gtr:id><gtr:title>The crystal structure of UMP kinase from Bacillus anthracis (BA1797) reveals an allosteric nucleotide-binding site.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d268ecc49a5272643ed4271589cadb13"><gtr:id>d268ecc49a5272643ed4271589cadb13</gtr:id><gtr:otherNames>Meier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>73C127B35B7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76ED1D27-5D2E-41C9-B370-C4826529421B</gtr:id><gtr:title>Crystal structure of a 3-oxoacyl-(acylcarrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-A resolution.</gtr:title><gtr:parentPublicationTitle>Proteins</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5dfa57ca9d60b68654d1b608104fee46"><gtr:id>5dfa57ca9d60b68654d1b608104fee46</gtr:id><gtr:otherNames>Zaccai NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0887-3585</gtr:issn><gtr:outcomeId>228D336E1D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0B18AB3-A57D-4DA4-8902-6AA0540A8805</gtr:id><gtr:title>Protein production and purification.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81659def67ccd83c9bda4f620b386e0f"><gtr:id>81659def67ccd83c9bda4f620b386e0f</gtr:id><gtr:otherNames>Structural Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>042CDDB0021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E99C84C-1081-4D29-BE35-05BF128C9801</gtr:id><gtr:title>Eukaryotic expression: developments for structural proteomics.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53cd70c2c528ff9abb11a980a68b8eec"><gtr:id>53cd70c2c528ff9abb11a980a68b8eec</gtr:id><gtr:otherNames>Aricescu AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>hroK3apVDdJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99F55DCE-5A23-4547-8F56-69A8FF8CF872</gtr:id><gtr:title>Lysine methylation as a routine rescue strategy for protein crystallization.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a351128a5243f5c920fb1009f9f34921"><gtr:id>a351128a5243f5c920fb1009f9f34921</gtr:id><gtr:otherNames>Walter TS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>1CFCF9FC096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7B41E76-9DBB-48D4-BA32-A5E4EF859EE3</gtr:id><gtr:title>First steps towards effective methods in exploiting high-throughput technologies for the determination of human protein structures of high biomedical value.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eafd81fb2fff553b9918a8057b672855"><gtr:id>eafd81fb2fff553b9918a8057b672855</gtr:id><gtr:otherNames>Banci L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>QW7P4EtHzKh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1B1A549-57C7-4CCB-9013-16F170B92587</gtr:id><gtr:title>Honing the in silico toolkit for detecting protein disorder.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section D, Biological crystallography</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/869b69c01a7d76e15c5ab6cf9007b404"><gtr:id>869b69c01a7d76e15c5ab6cf9007b404</gtr:id><gtr:otherNames>Esnouf RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0907-4449</gtr:issn><gtr:outcomeId>B67FC2ED7CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74669E18-1126-4799-88C0-39F804E599F2</gtr:id><gtr:title>The VIZIER project: preparedness against pathogenic RNA viruses.</gtr:title><gtr:parentPublicationTitle>Antiviral research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdae954279a53ed755071fb260a0769"><gtr:id>8cdae954279a53ed755071fb260a0769</gtr:id><gtr:otherNames>Coutard B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0166-3542</gtr:issn><gtr:outcomeId>8BA027F723E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5D13224-0949-46B2-9CD8-0E8D00277DA4</gtr:id><gtr:title>Structure of 5-formyltetrahydrofolate cyclo-ligase from Bacillus anthracis (BA4489).</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d268ecc49a5272643ed4271589cadb13"><gtr:id>d268ecc49a5272643ed4271589cadb13</gtr:id><gtr:otherNames>Meier C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>08E1A3880E9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400717</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>